Literature DB >> 7240227

Amine transport in chromaffin granule ghosts. pH dependence implies cationic form is translocated.

J Knoth, J M Isaacs, D Njus.   

Abstract

Chromaffin granules have a translocator-mediated uptake system for the monoamines dopamine, serotonin, norepinephrine, and epinephrine. These substrates are predominantly cationic at physiological pH but they also exist in neutral, zwitterionic, and anionic forms. The cationic fraction is nearly pH-independent between pH 6.9 and pH 7.6. Over the same pH range, the neutral and zwitterionic fractions increase by a factor of 6.3 and the anionic fraction increases by a factor of 40. In chromaffin granule ghosts, the apparent Km values for dopamine and serotonin transport are independent of pH between 6.8 and 7.6. Consequently, the translocator probably binds the cationic form of the substrate. Vmax values for dopamine and serotonin uptake increase by a factor of 2 between pH 6.8 and pH 7.6.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240227

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

Review 2.  A molecular description of nerve terminal function.

Authors:  L F Reichardt; R B Kelly
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Uptake of norepinephrine and related catecholamines by cultured chromaffin cells: characterization of cocaine-sensitive and -insensitive plasma membrane transport sites.

Authors:  D K Banerjee; R A Lutz; M A Levine; D Rodbard; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Does the carrier of chromaffin granules transport the protonated or the uncharged species of catecholamines?

Authors:  G Kobold; R Langer; A Burger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

Review 5.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 6.  Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.

Authors:  Kandatege Wimalasena
Journal:  Med Res Rev       Date:  2010-02-04       Impact factor: 12.944

7.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

8.  Chemical evidence that catecholamines are transported across the chromaffin granule membrane as noncationic species.

Authors:  A Ramu; M Levine; H Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Vmat2 heterozygous mutant mice display a depressive-like phenotype.

Authors:  Masato Fukui; Ramona M Rodriguiz; Jiechun Zhou; Sara X Jiang; Lindsey E Phillips; Marc G Caron; William C Wetsel
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

10.  Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.

Authors:  Michael K Sievert; Abdol R Hajipour; Arnold E Ruoho
Journal:  Anal Biochem       Date:  2007-05-03       Impact factor: 3.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.